OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
Jonas Steenbrugge(Ghent University), Evelyne Meyer(Ghent University)
Cited by 6
Related Papers
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
|Nature Communications|2022|176
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2018|123
Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions
|Cell Death and Differentiation|2025|8
Targeting ferroptosis protects against multiorgan dysfunction and death.
|Research Square|2021|1